6 citations
,
January 2018 in “Annals of dermatology/Annals of Dermatology” Hyaluronic acid filler can safely and effectively improve facial contour in Parry-Romberg Syndrome.
3 citations
,
March 2024 in “Cureus” Platelet-Rich Plasma (PRP) helps reduce jaw pain and improve function in young adults with mild TMJ disorder.
31 citations
,
March 2020 in “International Journal of Regenerative Medicine” PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.
10 citations
,
January 1995 in “Dermatology” Dermatologists should consider congenital syndromes like TRPS in young adults with early hair loss.
2 citations
,
November 2012 in “Archimer (Ifremer)” Marxan is better for designing Marine Protected Areas in the Eastern English Channel.
April 2024 in “Journal of translational medicine” MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.
February 2023 in “Journal of Dermatological Treatment” Minoxidil and PRP both help with hair growth, but Minoxidil has higher satisfaction and fewer side effects.
RNase L hinders hair follicle regeneration by altering immune signals.
August 2025 in “Cermin Dunia Kedokteran” HMPV causes respiratory infections, mainly managed with supportive care, and lacks a vaccine or specific treatment.
January 2025 in “Biomedical Engineering Letters” MXD@CP could be a promising new topical treatment for hair loss.
1 citations
,
April 2021 in “The journal of investigative dermatology/Journal of investigative dermatology” mTORC1 activity is important for hair growth and color, and targeting it could help treat hair loss and greying.
November 2025 in “Zenodo (CERN European Organization for Nuclear Research)” PRP may be more effective and satisfying for hair regrowth than minoxidil, with similar safety.
Combining PRP with minoxidil improves hair growth more than minoxidil alone.
A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.
74 citations
,
October 2015 in “Experimental Dermatology” Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.
9 citations
,
March 2024 in “Journal of Biomaterials Applications” Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.
1 citations
,
January 2022 in “Journal of Cutaneous and Aesthetic Surgery” Combining 5% minoxidil with platelet-rich plasma is more effective for hair loss than minoxidil alone.
Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.
10 citations
,
March 2021 in “Annals of palliative medicine” PRP shows promise in healing but needs a standardized, safe preparation method.
4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.
52 citations
,
October 1999 in “Developmental Dynamics” Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.
1 citations
,
September 2022 in “Aesthetic Surgery Journal”
1 citations
,
January 2013 in “MedChemComm” PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.
January 2020 in “Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)” Polycomb Repressive Complex 1 is crucial for keeping stem cells stable and maintaining healthy adult tissues.
5 citations
,
April 2025 in “Journal of Functional Biomaterials” A-PRF+ improves bone healing and stability in oral surgery.
Parry Romberg syndrome requires awareness and teamwork in primary care for proper diagnosis and management.
October 2025 in “Infection Control and Hospital Epidemiology” Standardized protocols are crucial for safe and infection-free platelet-rich plasma therapy.
11 citations
,
July 2023 in “Applied Nanoscience”
January 2025 in “Journal of Plastic Reconstructive & Aesthetic Surgery” Two L-PRP treatments improve hair density in mild to moderate alopecia.
February 2023 in “Military Medical Science Letters” Platelet-rich plasma treatments reduce knee osteoarthritis inflammation, with pure PRP being more effective.